Jacobs Levy Equity Management Inc. purchased a new stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) in the first quarter, according to its most recent filing with the SEC. The firm purchased 24,270 shares of the medical instruments supplier's stock, valued at approximately $28,661,000. Jacobs Levy Equity Management Inc. owned 0.12% of Mettler-Toledo International at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of MTD. GAMMA Investing LLC raised its holdings in Mettler-Toledo International by 131,246.3% in the 1st quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier's stock valued at $456,018,000 after acquiring an additional 385,864 shares during the last quarter. Alliancebernstein L.P. lifted its holdings in Mettler-Toledo International by 21.6% in the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier's stock worth $837,653,000 after buying an additional 126,147 shares in the last quarter. Nuveen LLC acquired a new position in Mettler-Toledo International in the 1st quarter worth $71,897,000. AustralianSuper Pty Ltd lifted its holdings in Mettler-Toledo International by 60.4% in the 1st quarter. AustralianSuper Pty Ltd now owns 114,986 shares of the medical instruments supplier's stock worth $135,788,000 after buying an additional 43,313 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. lifted its holdings in Mettler-Toledo International by 11.9% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier's stock worth $479,673,000 after buying an additional 43,082 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.
Mettler-Toledo International Price Performance
Shares of Mettler-Toledo International stock traded up $30.36 on Thursday, hitting $1,283.23. The company had a trading volume of 28,430 shares, compared to its average volume of 169,230. The business has a 50-day simple moving average of $1,256.54 and a 200-day simple moving average of $1,186.62. The company has a market cap of $26.43 billion, a PE ratio of 32.49, a PEG ratio of 3.86 and a beta of 1.37. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,521.01.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. The firm had revenue of $983.22 million during the quarter, compared to analysts' expectations of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The firm's revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period last year, the firm posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of brokerages have commented on MTD. Bank of America boosted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a report on Thursday, June 26th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their target price for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Citigroup increased their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research note on Thursday, August 21st. Barclays began coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 24th. They set an "overweight" rating and a $1,325.00 price objective on the stock. Finally, Robert W. Baird increased their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Mettler-Toledo International presently has a consensus rating of "Moderate Buy" and a consensus target price of $1,311.11.
Get Our Latest Report on MTD
Insider Buying and Selling
In related news, CFO Shawn Vadala sold 300 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total value of $397,500.00. Following the completion of the sale, the chief financial officer owned 5,095 shares in the company, valued at approximately $6,750,875. This represents a 5.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gerry Keller sold 165 shares of the company's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the sale, the insider owned 94 shares of the company's stock, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,827 shares of company stock worth $2,371,208. Corporate insiders own 1.94% of the company's stock.
Mettler-Toledo International Profile
(
Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Featured Stories

Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report